Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531–62.

Article  CAS  PubMed  Google Scholar 

Caza T, Landas S. Functional and phenotypic plasticity of CD4(+) T cell subsets. Biomed Res Int. 2015;2015: 521957.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Y, Guo J, Jia R. Treg: a promising immunotherapeutic target in oral diseases. Front Immunol. 2021;12: 667862.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med. 1996;184:387–96.

Article  CAS  PubMed  Google Scholar 

Weissler KA, Caton AJ. The role of T-cell receptor recognition of peptide: MHC complexes in the formation and activity of Foxp3(+) regulatory T cells. Immunol Rev. 2014;259:11–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jordan MS, Boesteanu A, Reed AJ, Petrone AL, Holenbeck AE, Lerman MA, et al. Thymic selection of CD4+CD25+regulatory T cells induced by an agonist self-peptide. Nat Immunol. 2001;2:301–6.

Article  CAS  PubMed  Google Scholar 

Shevach EM, Thornton AM. tTregs, pTregs, and iTregs: similarities and differences. Immunol Rev. 2014;259:88–102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Polansky JK, Kretschmer K, Freyer J, Floess S, Garbe A, Baron U, et al. DNA methylation controls Foxp3 gene expression. Eur J Immunol. 2008;38:1654–63.

Article  CAS  PubMed  Google Scholar 

Georgiev P, Charbonnier LM, Chatila TA. Regulatory T cells: the many faces of Foxp3. J Clin Immunol. 2019;39:623–40.

Article  PubMed  PubMed Central  Google Scholar 

Wildin RS, Fred R, Peake J, Faravelli F, Casanova JL, Buist N, Levy Lahad E, Mazzella M, Goulet O, Perroni L, Dagna Bricarelli F, Byrne G, McEuen M, Proll S, Appleby M, Brunkow ME. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27:20–1.

Article  Google Scholar 

Yang WY, Shao Y, Lopez-Pastrana J, Mai J, Wang H, Yang XF. Pathological conditions re-shape physiological Tregs into pathological Tregs. Burns Trauma. 2015;3:1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arterbery AS, Osafo-Addo A, Avitzur Y, Ciarleglio M, Deng Y, Lobritto SJ, et al. Production of proinflammatory cytokines by monocytes in liver-transplanted recipients with de novo autoimmune hepatitis is enhanced and induces TH1-like regulatory T cells. J Immunol. 2016;196:4040–51.

Article  CAS  PubMed  Google Scholar 

Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. T-bet controls regulatory T cell homeostasis and function during type-1 inflammation. Nat Immunol. 2009;10:595–602.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng Y, Chaudhry A, Kas A, deRoos P, Kim JM, Chu TT, Corcoran L, Treuting P, Klein U, Rudensky AY. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses. Nature. 2009;458:351–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y, Kas A, et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science. 2009;326:986–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dominguez-Villar M, Hafler DA. Regulatory T cells in autoimmune disease. Nat Immunol. 2018;19:665–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hatzioannou A, Boumpas A, Papadopoulou M, Papafragkos I, Varveri A, Alissafi T, et al. Regulatory T cells in autoimmunity and cancer: a duplicitous lifestyle. Front Immunol. 2021;12: 731947.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dominguez-Villar M, Baecher-Allan CM, Hafler DA. Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease. Nat Med. 2011;17:673–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sakaguchi S, Mikami N, Wing JB, Tanaka A, Ichiyama K, Ohkura N. Regulatory T cells and human disease. Annu Rev Immunol. 2020;38:541–66.

Article  CAS  PubMed  Google Scholar 

Nyirenda MH, Morandi E, Vinkemeier U, Constantin-Teodosiu D, Drinkwater S, Mee M, et al. TLR2 stimulation regulates the balance between regulatory T cell and Th17 function: a novel mechanism of reduced regulatory T cell function in multiple sclerosis. J Immunol. 2015;194:5761–74.

Article  CAS  PubMed  Google Scholar 

Di Giovangiulio M, Rizzo A, Franze E, Caprioli F, Facciotti F, Onali S, et al. Tbet expression in regulatory T cells is required to initiate Th1-mediated colitis. Front Immunol. 2019;10:2158.

Article  PubMed  PubMed Central  Google Scholar 

McClymont SA, Putnam AL, Lee MR, Esensten JH, Liu W, Hulme MA, et al. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J Immunol. 2011;186:3918–26.

Article  CAS  PubMed  Google Scholar 

Gao N, Cui W, Zhao L-M, Li T-T, Zhang JH, Pan L-L. Contribution of Th2-like Treg cells to the pathogenesis of Takayasu’s arteritis. Clin Exp Rheumatol. 2020;38:S48–54.

Google Scholar 

Saigusa R, Asano Y, Taniguchi T, Hirabayashi M, Nakamura K, Miura S, et al. Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells. Arthritis Res Ther. 2018;20:23.

Article  PubMed  PubMed Central  Google Scholar 

Tseng WY, Huang YS, Clanchy F, McNamee K, Perocheau D, Ogbechi J, et al. TNF receptor 2 signaling prevents DNA methylation at the Foxp3 promoter and prevents pathogenic conversion of regulatory T cells. Proc Natl Acad Sci U S A. 2019;116:21666–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Komatsu N, Okamoto K, Sawa S, Nakashima T, Oh-hora M, Kodama T, et al. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat Med. 2014;20:62–8.

Article  CAS  PubMed  Google Scholar 

Bovenschen HJ, van de Kerkhof PC, van Erp PE, Woestenenk R, Joosten I, Koenen HJ. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J Invest Dermatol. 2011;131:1853–60.

Article  CAS  PubMed  Google Scholar 

Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007;110:1225–32.

Article  CAS  PubMed  Google Scholar 

Gao X, Zhu Y, Li G, Huang H, Zhang G, Wang F, et al. TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression. PLoS ONE. 2012;7: e30676.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gautron AS, Dominguez-Villar M, de Marcken M, Hafler DA. Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells. Eur J Immunol. 2014;44:2703–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sakuishi K, Ngiow SF, Sullivan JM, Teng MWL, Kuchroo VK, Smythand MJ, Anderson AC. TIM3+FOXP3+ regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer. OncoImmunology. 2013;2:e23849.

Article  PubMed  PubMed Central  Google Scholar 

Ayyouba M, Deknuydt F, Raimbauda I, Dousseta C, Levequea L, Bioleya G, Valmoria D. Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor ROR t. PNAS. 2009;106:8635–40.

Article  Google Scholar 

Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martinez-Llordella M, Ashby M, et al. Foxp3 instability leads to the generation of pathogenic memory T cells in vivo. Nat Immunol. 2009;10:1000–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou L, Lopes JE, Chong MMW, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, Ziegler SF, Littman DR. TGF-β-induced Foxp3 inhibits Th17 cell differentiation by antagonizing RORγt function. Nature. 2008;453:236–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wei G, Wei L, Zhu J, Zang C, Hu-Li J, Yao Z, et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity. 2009;30:155–67.

Article  PubMed